Table 2 Evidence for CSMD1 variant pathogenicity from in silico tools, deep learning-based protein modeling, and population data. N/A, not applicable.
Variant (NM_033225.6) | VAFa | Homozygous individualsa | ACMG Classification | Chain | CADD Phred scoreb | SIFTb,c | PolyPhen-2 HDIVb,d | DDmut ΔΔG Stability (kcal/mol)e | Study |
|---|---|---|---|---|---|---|---|---|---|
c.412 G > A, p.E138K | 0 | 0 | VUS | A | 24.1 | 0 | 0.998 | -0.25 | present |
c.559 G > A, p.V187I | <0.0005 | 0 | VUS | A | 17.5 | 0 | 0.414 | 0.03 | present |
c.563 G > A, p.S188N | <0.001 | 0 | VUS | A | 17.5 | 0 | 0.224 | -0.09 | Costanzo et al., 2022f |
c.638 G > T, p.R213L | 0 | 0 | VUS | A | 24.4 | 0 | 0.990 | 0.10 | present |
c.1507 C > A, p.H503N | <0.0001 | 0 | VUS | A | 24.4 | 0 | 0.992 | 0.81 | present |
c.4920 C > A, p.N1640K | 0 | 0 | VUS | A | 22.6 | 0.01 | 0.634 | -0.34 | present |
c.5852 C > T, p.S1951F | 0 | 0 | VUS | A | 29.8 | 0 | 0.999 | -0.04 | present |
c.5344 C > A, p.Q1782K | <0.005 | 0 | VUS | A | 19.2 | 0.05 | 0.227 | 0.05 | Costanzo et al., 2022f |
c.6762 G > C, p.Q2254H | 0 | 0 | VUS | A | 19.7 | 0.37 | 0.001 | 0.03 | present |
c.6886 G > A, p.D2296N | <0.00005 | 0 | VUS | A | 22.8 | 0.07 | 0.948 | 0.14 | present |
c.7285+2 T > C | 0 | 0 | VUS | N/A | 30.0 | N/A | N/A | NA | present |
c.7322 G > C, p.G2441A | 0 | 0 | VUS | A | 23.5 | 0 | 1.000 | -0.70 | present |
c.8850 C > G, p.H2950Q | 0 | 0 | VUS | A | 22.0 | 0.07 | 0.087 | -0.53 | present |
c.9424 G > A, p.V3142M | <0.00005 | 0 | VUS | A | 22.5 | 0.01 | 0.730 | -0.53 | present |